FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Rubin

Research Profile

Disorders

Chemicals & Drugs

Physiology

Procedures

Anatomy

Devices

Oligonucleotide Array Sequence Analysis

Concepts & Ideas

Cohort Studies

Co-author Network

Publications

TOP 3
Juan Miguel Mosquera; Mark A Rubin; Andrea Sboner; Chandrika Sreekantaiah; Yun Shao Sung; Leonard H Wexler; Lei Zhang; Chun-Liang Chen; Morris Edelman; Naoki Kitabayashi; Michael P LaQuaglia; Cristina R Antonescu
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.
Himisha Beltran; Maureen T Cronin; Sean R Downing; Garrett M Frampton; Mirna Jarosz; Doron Lipson; Theresa Y MacDonald; Juan Miguel Mosquera; David M Nanus; Kyung Park; Philip J Stephens; Scott T Tagawa; Roman Yelensky; Mark A Rubin
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
Pei-Chun Lin; Juan Miguel Mosquera; Kyung Park; Mark A Rubin; Andrea Sboner; Ashutosh K Tewari; Himisha Beltran; Levi A Garraway; Eugenia G Giannopoulou; Olivier Elemento
Epigenomic alterations in localized and advanced prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Rubin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Juan Miguel Mosquera; Mark A Rubin; Andrea Sboner; Chandrika Sreekantaiah; Yun Shao Sung; Leonard H Wexler; Lei Zhang; Chun-Liang Chen; Morris Edelman; Naoki Kitabayashi; Michael P LaQuaglia; Cristina R Antonescu
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.
Genes, chromosomes & cancer 2013;52(6):538-50.
2013: Himisha Beltran; Maureen T Cronin; Sean R Downing; Garrett M Frampton; Mirna Jarosz; Doron Lipson; Theresa Y MacDonald; Juan Miguel Mosquera; David M Nanus; Kyung Park; Philip J Stephens; Scott T Tagawa; Roman Yelensky; Mark A Rubin
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
European urology 2013;63(5):920-6.
2013: Pei-Chun Lin; Juan Miguel Mosquera; Kyung Park; Mark A Rubin; Andrea Sboner; Ashutosh K Tewari; Himisha Beltran; Levi A Garraway; Eugenia G Giannopoulou; Olivier Elemento
Epigenomic alterations in localized and advanced prostate cancer.
Neoplasia (New York, N.Y.) 2013;15(4):373-83.
2013: Himisha Beltran; Mark A Rubin
New strategies in prostate cancer: translating genomics into the clinic.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(3):517-23.
2013: Pei-Chun Lin; Ari M Melnick; Juan Miguel Mosquera; Kyung Park; Ashutosh K Tewari; Pedro Alves; Samprit Banerjee; Himisha Beltran; Ya-Lin Chiu; Francesca Demichelis; Olivier Elemento; Mark B Gerstein; Eugenia Giannopoulou; Mark A Rubin
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.
Cancer research 2013;73(3):1232-44.
2013: Juan Miguel Mosquera; David M Nanus; Joel B Nelson; Kyung Park; Sven Perner; Brian D Robinson; Himisha Beltran; Tarek A Bismar; Rajiv Dhir; Andreas Erbersdobler; Theresa Y MacDonald; Scott T Tagawa; Mark A Rubin
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
Neoplasia (New York, N.Y.) 2013;15(1):1-10.
2013: Maria Poptsova; Mark A Rubin; Samprit Banerjee; Omer Gokcumen; Francesca Demichelis
Impact of constitutional copy number variants on biological pathway evolution.
BMC evolutionary biology 2013;13():19.
2012: Himisha Beltran; Theresa MacDonald; Matthew I Milowsky; Juan Miguel Mosquera; Kyung Park; Mark A Rubin; Scott T Tagawa; David M Nanus
Challenges in recognizing treatment-related neuroendocrine prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):e386-9.
2012: Rui Wang; Heng Zheng; Irfan A Asangani; Bushra Ateeq; Daniel F Camacho; Qi Cao; Balabhadrapatruni V S K Chakravarthi; Arul M Chinnaiyan; Saravana M Dhanasekaran; Xiaojun Jing; Lakshmi P Kunju; Robert J Lonigro; Ram-Shankar Mani; Natalie McGregor; Rohit Mehra; Radhika Menawat; Mukesh K Nyati; Arie P Otte; Nallasivam Palanisamy; Kenneth J Pienta; Mark A Rubin; Taibriana E W Schumann; Javed Siddiqui; Scott A Tomlins; Sooryanarayana Lnu
Role of transcriptional corepressor CtBP1 in prostate cancer progression.
Neoplasia (New York, N.Y.) 2012;14(10):905-14.
2012: Olivier Elemento; Mark A Rubin; David S Rickman
Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer.
Cell cycle (Georgetown, Tex.) 2012;11(18):3380-3.
2012: David S Rickman; T David Soong; Stéphane Terry; Joseph Tripodi; Karen Bunting; Francesca Demichelis; Jan Dlabal; Olivier Elemento; Theresa Y MacDonald; Ari M Melnick; Juan Miguel Mosquera; Benjamin Moss; Vesna Najfeld; Mark A Rubin
Oncogene-mediated alterations in chromatin conformation.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(23):9083-8.
2012: Raquel Esgueva; Robert Kim; Naoki Kitabayashi; Robert A Leung; Kyung Park; David S Rickman; Mark A Rubin; Maria M Shevchuk; Stéphane Terry; Ashutosh K Tewari; Cyril Abraham; Samprit Banerjee; Christopher E Barbieri; Philip J Dorsey
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2012;21(2):61-8.
2012: Francesca Demichelis; Olivier Elemento; Sagit Goldenberg; Wolfgang Horninger; Julie Huang; Michale Kearney; Naoki Kitabayashi; Helmut Klocker; Charles Lee; Derek A Oldridge; Meredith M Regan; David S Rickman; Samprit Banerjee; Georg Bartsch; Jasmin Bektic; Himisha Beltran; Dimple Chakravarty; Chen X Chen; Jin Yun Helen Chen; Arul M Chinnaiyan; Martin A Sanda; Georg Schaefer; Douglas S Scherr; Sunita R Setlur; Javed Siddiqui; T David Soong; Birgit Stenzel; John T Wei; Mark A Rubin
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(17):6686-91.
2012: John R Prensner; Mark A Rubin; John T Wei; Arul M Chinnaiyan
Beyond PSA: the next generation of prostate cancer biomarkers.
Science translational medicine 2012;4(127):127rv3.
2011: Himisha Beltran; Sung Suk Chae; Arul M Chinnaiyan; Colin C Collins; Alexandre de la Taille; Francesca Demichelis; Rajiv Dhir; Mark B Gerstein; Martin E Gleave; Theresa Y MacDonald; David M Nanus; Joel B Nelson; Kyung Park; Sven Perner; Kenneth J Pienta; David S Rickman; Andrea Sboner; Karen L Sheikh; Scott T Tagawa; Stéphane Terry; Yuwei Wang; Yuzhuo Wang; Yves Allory; Mark A Rubin
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
Cancer discovery 2011;1(6):487-95.
2011: Patrick L Wagner; Walter Weder; Theresia Wilbertz; Nasser K Altorki; Falko Fend; Roopika Menon; Ralf Mikut; Holger Moch; Karen Petersen; Markus Reischl; Mark A Rubin; Veit Scheble; Alex Soltermann; Ann-Cathrin Stiedl; Sven Perner
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 2011;74(1):118-23.
2011: Mark A Rubin; Christopher A. Maher; Arul M Chinnaiyan
Common gene rearrangements in prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(27):3659-68.
2011: Scott A Tomlins; Radhika Varambally; Lei Wang; John T Wei; Sarah Williamsen; David Wood; James B Amberson; Sheila M J Aubin; Amy Blase; John R Day; Yves Fradet; Jack Groskopf; Bo Han; Petrea Hodge; Brent K Hollenbeck; Robert J Lonigro; Jessica Meinke; Stephanie Meyers; Siobhan Miick; Nallasivam Palanisamy; Yvonne Penabella; Daniel R Rhodes; Harry G Rittenhouse; Mark A Rubin; Kyoko Sakamoto; Martin G Sanda; Laurie Sefton-Miller; Javed Siddiqui; Jonathan L Silberstein; Arul M Chinnaiyan
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.
Science translational medicine 2011;3(94):94ra72.
2011: Aurélien Descazeaud; Francois Labrousse; Grégoire Robert; Mark A Rubin; Francis Vacherot; Nicolas Weinbreck; Claude C Abbou; Yves Allory; Alexandre de la Taille
Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.
BJU international 2011;108(2 Pt 2):E23-8.
2011: Xiao-Song Wang; Anastasia K Yocum; Irfan A Asangani; Bushra Ateeq; Lewis C Cantley; Qi Cao; Xuhong Cao; Saravana M Dhanasekaran; Daniel F Fries; Anuradha Gopalan; Bo Han; Xiaojun Jing; Emily Rose Kahoud; Yong Li; Gilbert S Omenn; Nallasivam Palanisamy; Dorothee Pflueger; John R Prensner; Victor E Reuter; Daniel Robinson; Mark A Rubin; Atsuo T Sasaki; Sunita Shankar; Sooryanarayana Lnu; Rui Wang; Arul M Chinnaiyan
Characterization of KRAS rearrangements in metastatic prostate cancer.
Cancer discovery 2011;1(1):35-43.
2011: Maria A Svensson; Christopher J LaFargue; Theresa Y MacDonald; Dorothee Pflueger; Naoki Kitabayashi; Ashley M Santa-Cruz; Karl E Garsha; Ubaradka G Sathyanarayana; Janice P Riley; Chol S Yun; Dea Nagy; Jerry W Kosmeder; Gary A Pestano; Ashutosh K Tewari; Francesca Demichelis; Mark A Rubin
Testing mutual exclusivity of ETS rearranged prostate cancer.
Laboratory investigation; a journal of technical methods and pathology 2011;91(3):404-12.
2011: Dorothee Pflueger; stephane terry; Andrea Sboner; Lukas Habegger; Raquel Esgueva; Pei-Chun Lin; Maria A Svensson; Naoki Kitabayashi; Benjamin J Moss; Theresa Y MacDonald; Xuhong Cao; Terrence Barrette; Ashutosh K Tewari; Mark S Chee; Arul M Chinnaiyan; David S Rickman; Francesca Demichelis; Mark B Gerstein; Mark A Rubin
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.
Genome research 2011;21(1):56-67.
2010: David S Rickman; Ying-bei Chen; Samprit Banerjee; Yihang Pan; Jindan Yu; Terry Vuong; Sven Perner; Christopher J Lafargue; Kirsten D Mertz; Sunita R Setlur; Kanishka Sircar; Arul M Chinnaiyan; Tarek A Bismar; Mark A Rubin; Francesca Demichelis
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.
Neoplasia (New York, N.Y.) 2010;12(12):1031-40.
2010: Ashutosh K Tewari; Nishant D Patel; Robert A Leung; Rajiv Yadav; E Darracott Vaughan; Youssef El-Douaihy; Jiangling J Tu; Muhul B Amin; Mohammed Akhtar; Mark Burns; Usha Kreaden; Mark A Rubin; Atsushi Takenaka; Maria M Shevchuk
Visual cues as a surrogate for tactile feedback during robotic-assisted laparoscopic prostatectomy: posterolateral margin rates in 1340 consecutive patients.
BJU international 2010;106(4):528-36.
2010: Raquel Esgueva; Sven Perner; Christopher J LaFargue; Veit Scheble; Carsten Stephan; Michael Lein; Florian R Fritzsche; Manfred Dietel; Glen Kristiansen; Mark A Rubin
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(4):539-46.
2010: Sven Perner; Maria A Svensson; Ruhella R Hossain; John R Day; Jack Groskopf; Ryan C Slaughter; Analee R Jarleborn; Matthias D Hofer; Rainer Kuefer; Francesca Demichelis; David S Rickman; Mark A Rubin
ERG rearrangement metastasis patterns in locally advanced prostate cancer.
Urology 2010;75(4):762-7.
2010: Andrea Sboner; Francesca Demichelis; Stefano Calza; Yudi Pawitan; Sunita R Setlur; Yujin Hoshida; Sven Perner; Hans-Olov Adami; Katja Fall; Lorelei A Mucci; Philip W Kantoff; Meir Stampfer; Swen-Olof Andersson; Eberhard Varenhorst; Jan-Erik Johansson; Mark B Gerstein; Todd R Golub; Mark A Rubin; Ove Andrén
Molecular sampling of prostate cancer: a dilemma for predicting disease progression.
BMC medical genomics 2010;3():8.
2010: Sunita R Setlur; Chen X Chen; Ruhella R Hossain; Jung Sook Ha; Vanessa E Van Doren; Birgit Stenzel; Eberhard Steiner; Derek Oldridge; Naoki Kitabayashi; Samprit Banerjee; Jin Yun Chen; Georg Schäfer; Wolfgang Horninger; Charles Lee; Mark A Rubin; Helmut Klocker; Francesca Demichelis
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(1):229-39.
2009: Alex H Ramos; Amit Dutt; Craig Mermel; Sven Perner; Jeonghee Cho; Christopher J Lafargue; Laura A Johnson; Ann-Cathrin Stiedl; Kumiko E Tanaka; Adam J Bass; Jordi Barretina; Barbara A Weir; Rameen Beroukhim; Roman K Thomas; John D Minna; Lucian R Chirieac; Neal Lindeman; Thomas J Giordano; David G Beer; Patrick Wagner; Ignacio I Wistuba; Mark A Rubin; Matthew Meyerson
Amplification of chromosomal segment 4q12 in non-small cell lung cancer.
Cancer biology & therapy 2009;8(21):2042-50.
2009: Sue Ellen Touma; Sven Perner; Mark A Rubin; David M Nanus; Lorraine J Gudas
Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.
Biochemical pharmacology 2009;78(9):1127-38.
2009: Patrick L Wagner; Sven Perner; David S Rickman; Christopher J LaFargue; Naoki Kitabayashi; Stephen F Johnstone; Barbara A Weir; Matthew Meyerson; Nasser K Altorki; Mark A Rubin
In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma.
American journal of clinical pathology 2009;132(4):500-5.
2009: Dorothee Pflueger; David S Rickman; Andrea Sboner; Sven Perner; Christopher J LaFargue; Maria A Svensson; Benjamin J Moss; Naoki Kitabayashi; Yihang Pan; Alexandre de la Taille; Rainer Kuefer; Ashutosh K Tewari; Francesca Demichelis; Mark S Chee; Mark B Gerstein; Mark A Rubin
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
Neoplasia (New York, N.Y.) 2009;11(8):804-11.
2009: Scott A Tomlins; Anders Bjartell; Arul M Chinnaiyan; Guido Jenster; Robert K Nam; Mark A Rubin; Jack A Schalken
ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
European urology 2009;56(2):275-86.
2009: Justine A Barletta; Sven Perner; A John Iafrate; Beow Y Yeap; Barbara A Weir; Laura A Johnson; Bruce E Johnson; Matthew Meyerson; Mark A Rubin; William D Travis; Massimo Loda; Lucian R Chirieac
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
Journal of cellular and molecular medicine 2009;13(8B):1977-86.
2009: Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan YU; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
Cell 2009;138(2):245-56.
2009: Juan-Miguel Mosquera; Rohit Mehra; Meredith M Regan; Sven Perner; Elizabeth M Genega; Gerri Bueti; Rajal B Shah; Sandra Gaston; Scott A Tomlins; John T Wei; Michael C Kearney; Laura A Johnson; Jeffrey M Tang; Arul M Chinnaiyan; Mark A Rubin; Martin G Sanda
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(14):4706-11.
2009: Herbert Haack; Laura A Johnson; Christopher J Fry; Katherine Crosby; Roberto D Polakiewicz; Edward B Stelow; Seung-Mo Hong; Brian E Schwartz; Michael J Cameron; Mark A Rubin; Martin C Chang; Jon C Aster; Christopher A French
Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.
The American journal of surgical pathology 2009;33(7):984-91.
2009: Mara P Steinkamp; Orla A O'Mahony; Michele Brogley; Haniya Rehman; Elizabeth W Lapensee; Saravana M Dhanasekaran; Matthias D Hofer; Rainer Kuefer; Arul M Chinnaiyan; Mark A Rubin; Kenneth J Pienta; Diane M Robins
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.
Cancer research 2009;69(10):4434-42.
2009: Sunita R Setlur; Kirsten D Mertz; Mark A Rubin
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
BJU international 2009;103(9):1293; author reply 1293.
2009: David S Rickman; Dorothee Pflueger; Benjamin Moss; Vanessa E VanDoren; Chen X Chen; Alexandre de la Taille; Rainer Kuefer; Ashutosh K Tewari; Sunita R Setlur; Francesca Demichelis; Mark A Rubin
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
Cancer research 2009;69(7):2734-8.
2009: Francesca Demichelis; Sunita R Setlur; Rameen Beroukhim; Sven Perner; Jan O Korbel; Christopher J Lafargue; Dorothee Pflueger; Cara Pina; Matthias D Hofer; Andrea Sboner; Maria A Svensson; David S Rickman; Alex Urban; Michael Snyder; Matthew Meyerson; Charles Lee; Mark B Gerstein; Rainer Kuefer; Mark A Rubin
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
Genes, chromosomes & cancer 2009;48(4):366-80.
2009: Preet K Dhillon; Marc Barry; Meir J Stampfer; Sven Perner; Michelangelo Fiorentino; Alessandro Fornari; Jing Ma; Julia Fleet; Tobias Kurth; Mark A Rubin; Lorelei A Mucci
Aberrant cytoplasmic expression of p63 and prostate cancer mortality.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):595-600.
2009: Matthias D Hofer; Rainer Kuefer; Christiane Maier; Kathleen Herkommer; Sven Perner; Francesca Demichelis; Thomas Paiss; Walter Vogel; Mark A Rubin; Josef Hoegel
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
Cancer research 2009;69(2):640-6.
2009: Pamela L Paris; S Sridharan; A B Hittelman; Y Kobayashi; S Perner; G Huang; Jeff Simko; Peter Carroll; Mark A Rubin; Colin Collins
An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer.
Prostate cancer and prostatic diseases 2009;12(2):184-91.
2008: Sooryanarayana Lnu; Bharathi Laxman; Rohit Mehra; Qi Cao; Saravana M Dhanasekaran; Scott A Tomlins; Jill Granger; Adaikkalam Vellaichamy; Arun Sreekumar; Jianjun Yu; Wenjuan Gu; Ronglai Shen; Debashis Ghosh; Lorinda M Wright; Raleigh D Kladney; Rainer Kuefer; Mark A Rubin; Claus J Fimmel; Arul M Chinnaiyan
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.
Neoplasia (New York, N.Y.) 2008;10(11):1285-94.
2008: Kirsten D Mertz; Francesca Demichelis; Andrea Sboner; Michelle S Hirsch; Paola Dal Cin; Kirsten Struckmann; Martina Storz; Simone Scherrer; Daniel M Schmid; Räto T Strebel; Nicole M Probst-Hensch; Mark Gerstein; Holger Moch; Mark A Rubin
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
International journal of cancer. Journal international du cancer 2008;123(3):569-76.
2008: Lorelei A Mucci; Yudi Pawitan; Francesca Demichelis; Katja Fall; Jennifer R Stark; Hans-Olov Adami; Swen-Olof Andersson; Ove Andrén; Anna Eisenstein; Lars Holmberg; Wei Huang; Philip W Kantoff; Robert Kim; Sven Perner; Meir J Stampfer; Jan-Erik Johansson; Mark A Rubin
Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(7):1682-8.
2008: Sunita R Setlur; Kirsten D Mertz; Yujin Hoshida; Francesca Demichelis; Mathieu Lupien; Sven Perner; Andrea Sboner; Yudi Pawitan; Ove Andrén; Laura A Johnson; Jeff Tang; Hans-Olov Adami; Stefano Calza; Arul M Chinnaiyan; Daniel R Rhodes; Scott A Tomlins; Katja Fall; Lorelei A Mucci; Philip W Kantoff; Meir J Stampfer; Swen-Olof Andersson; Eberhard Varenhorst; Jan-Erik Johansson; Myles Brown; Todd R Golub; Mark A Rubin
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
Journal of the National Cancer Institute 2008;100(11):815-25.
2008: Juan-Miguel Mosquera; Sven Perner; Elizabeth M Genega; Martin G Sanda; Matthias D Hofer; Kirsten D Mertz; Pamela L Paris; Jeff Simko; Tarek A Bismar; Gustavo Ayala; Rajal B Shah; Massimo Loda; Mark A Rubin
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3380-5.
2008: Rohit Mehra; Scott A Tomlins; Jianjun Yu; Xuhong Cao; Lei Wang; Anjana Menon; Mark A Rubin; Kenneth J Pienta; Rajal B Shah; Arul M Chinnaiyan
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.
Cancer research 2008;68(10):3584-90.
2008: Yilin C Neeley; M Simo Arredouani; Brent K Hollenbeck; Marvin H Eng; Mark A Rubin; Martin G Sanda
Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
The Prostate 2008;68(7):715-27.
2008: Jennelle C Hodge; Bradley J Quade; Mark A Rubin; Elizabeth A Stewart; Paola Dal Cin; Cynthia C Morton
Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.
The American journal of pathology 2008;172(5):1403-10.
2008: Kimberly A Kelly; Sunita R Setlur; Robert Ross; Rajesh Anbazhagan; Peter Waterman; Mark A Rubin; Ralph Weissleder
Detection of early prostate cancer using a hepsin-targeted imaging agent.
Cancer research 2008;68(7):2286-91.
2008: Francesca Demichelis; Heidi Greulich; Jill A Macoska; Rameen Beroukhim; William R Sellers; Levi A Garraway; Mark A Rubin
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines.
Nucleic acids research 2008;36(7):2446-56.
2008: Scott A Tomlins; Bharathi Laxman; Sooryanarayana Lnu; Xuhong Cao; Jindan YU; Beth E Helgeson; Qi Cao; John R Prensner; Mark A Rubin; Rajal B Shah; Rohit Mehra; Arul M Chinnaiyan
Role of the TMPRSS2-ERG gene fusion in prostate cancer.
Neoplasia (New York, N.Y.) 2008;10(2):177-88.
2008: Lorelei A Mucci; Yudi Pawitan; Francesca Demichelis; Katja Fall; Jennifer R Stark; Hans-Olov Adami; Swen-Olof Andersson; Ove Andrén; Anna S Eisenstein; Lars Holmberg; Wei Huang; Philip W Kantoff; Sven Perner; Meir J Stampfer; Jan-Erik Johansson; Mark A Rubin
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(1):249-51.
2007: Sunita R Setlur; Thomas E Royce; Andrea Sboner; Juan-Miguel Mosquera; Francesca Demichelis; Matthias D Hofer; Kirsten D Mertz; Mark Gerstein; Mark A Rubin
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer.
Cancer research 2007;67(21):10296-303.
2007: Marc Barry; Sven Perner; Francesca Demichelis; Mark A Rubin
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications.
Urology 2007;70(4):630-3.
2007: Kirsten D Mertz; Francesca Demichelis; Robert Kim; Peter Schraml; Martina Storz; Pierre-André Diener; Holger Moch; Mark A Rubin
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer.
Human pathology 2007;38(10):1454-62.
2007: Ove Andrén; Katja Fall; Swen-Olof Andersson; Mark A Rubin; Tarek A Bismar; M Karlsson; Jan-Erik Johansson; L A Mucci
MUC-1 gene is associated with prostate cancer death: a 20-year follow-up of a population-based study in Sweden.
British journal of cancer 2007;97(6):730-4.
2007: Jung H Kim; Saravana M Dhanasekaran; Rohit Mehra; Scott A Tomlins; Wenjuan Gu; Jianjun Yu; Chandan Kumar; Xuhong Cao; Atreya Dash; Lei Wang; Debashis Ghosh; Kerby Shedden; James E Montie; Mark A Rubin; Kenneth J Pienta; Rajal B Shah; Arul M Chinnaiyan
Integrative analysis of genomic aberrations associated with prostate cancer progression.
Cancer research 2007;67(17):8229-39.
2007: Scott A Tomlins; Bharathi Laxman; Saravana M Dhanasekaran; Beth E Helgeson; Xuhong Cao; David S Morris; Anjana Menon; Xiaojun Jing; Qi Cao; Bo Han; Jindan YU; Lei Wang; James E Montie; Mark A Rubin; Kenneth J Pienta; Diane Roulston; Rajal B Shah; Sooryanarayana Lnu; Rohit Mehra; Arul M Chinnaiyan
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Nature 2007;448(7153):595-9.
2007: Francesca Demichelis; Katja Fall; Sven Perner; Ove Andrén; F Schmidt; Sunita R Setlur; Y Hoshida; Juan-Miguel Mosquera; Y Pawitan; Charles Lee; Hans-Olov Adami; L A Mucci; Philip W Kantoff; Swen-Olof Andersson; Arul M Chinnaiyan; J-E Johansson; Mark A Rubin
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
Oncogene 2007;26(31):4596-9.
2007: Sven Perner; Juan-Miguel Mosquera; Francesca Demichelis; Matthias D Hofer; Pamela L Paris; Jeff Simko; Colin Collins; Tarek A Bismar; Arul M Chinnaiyan; Angelo M DeMarzo; Mark A Rubin
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
The American journal of surgical pathology 2007;31(6):882-8.
2007: Juan-Miguel Mosquera; Sven Perner; Francesca Demichelis; Robert Kim; Matthias D Hofer; Kirsten D Mertz; Pamela L Paris; Jeff Simko; Colin Collins; Tarek A Bismar; Arul M Chinnaiyan; Mark A Rubin
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.
The Journal of pathology 2007;212(1):91-101.
2007: Rohit Mehra; Scott A Tomlins; Ronglai Shen; Owais Nadeem; Lei Wang; John T Wei; Kenneth J Pienta; Debashis Ghosh; Mark A Rubin; Arul M Chinnaiyan; Rajal B Shah
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(5):538-44.
2007: Sven Perner; Matthias D Hofer; Robert Kim; Rajal B Shah; Haojie Li; Peter Möller; Richard E Hautmann; Juergen E Gschwend; Rainer Kuefer; Mark A Rubin
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
Human pathology 2007;38(5):696-701.
2007: Mark E Prince; Mathew L Ubell; Jason Castro; Haruko Ogawa; Tetsuya Ogawa; Ajita Narayan; Augusto Paulino; Andrew Cole; Gregory T Wolf; Mark A Rubin; Robert H Lyons Jr; Carol R Bradford; Thomas Carey
Tissue-preserving approach to extracting DNA from paraffin-embedded specimens using tissue microarray technology.
Head & neck 2007;29(5):465-71.
2007: Kirsten D Mertz; Sunita R Setlur; Saravana M Dhanasekaran; Francesca Demichelis; Sven Perner; Scott A Tomlins; Joëlle Tchinda; Bharathi Laxman; Robert L Vessella; Rameen Beroukhim; Charles Lee; Arul M Chinnaiyan; Mark A Rubin
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
Neoplasia (New York, N.Y.) 2007;9(3):200-6.
2007: Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Xuhong Cao; Lei Wang; Saravana M Dhanasekaran; Shanker Kalyana-Sundaram; John T Wei; Mark A Rubin; Kenneth J Pienta; Rajal B Shah; Arul M Chinnaiyan
Integrative molecular concept modeling of prostate cancer progression.
Nature genetics 2007;39(1):41-51.
2006: Joanne N Davis; Kirk J Wojno; Stephanie Daignault; Matthias D Hofer; Rainer Kuefer; Mark A Rubin; Mark Day
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Cancer research 2006;66(24):11897-906.
2006: Pamela L Paris; Matthias D Hofer; Giancarlo Albo; Rainer Kuefer; Juergen E Gschwend; Richard E Hautmann; Jane Fridyland; Jeff Simko; Peter R Carroll; Mark A Rubin; Colin Collins
Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer.
Neoplasia (New York, N.Y.) 2006;8(12):1083-9.
2006: Bharathi Laxman; Scott A Tomlins; Rohit Mehra; David S Morris; Lei Wang; Beth E Helgeson; Rajal B Shah; Mark A Rubin; John T Wei; Arul M Chinnaiyan
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
Neoplasia (New York, N.Y.) 2006;8(10):885-8.
2006: Sven Perner; Francesca Demichelis; Rameen Beroukhim; Folke H Schmidt; Juan-Miguel Mosquera; Sunita R Setlur; Joëlle Tchinda; Scott A Tomlins; Matthias D Hofer; Kenneth J Pienta; Rainer Kuefer; Robert L Vessella; Xiao-Wei Sun; Matthew Meyerson; Charles Lee; William R Sellers; Arul M Chinnaiyan; Mark A Rubin
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
Cancer research 2006;66(17):8337-41.
2006: Matthias D Hofer; Coya Tapia; Tara-Jane Browne; Martina Mirlacher; Guido Sauter; Mark A Rubin
Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue.
Archives of pathology & laboratory medicine 2006;130(7):989-96.
2006: Aurélien Descazeaud; Alexandre de la Taille; Yves Allory; Hugo Faucon; Laurent Salomon; Tarek Bismar; Robert Kim; Matthias D Hofer; Dominique Chopin; Claude C Abbou; Mark A Rubin
Characterization of ZAG protein expression in prostate cancer using a semi-automated microscope system.
The Prostate 2006;66(10):1037-43.
2006: William K Oh; Julia Hayes; Carolyn Evan; Judith Manola; Daniel J George; Helen Waldron; Meaghan Donovan; John Varner; John Orechia; Beth Katcher; Diana Lu; Arthur Nevins; Renée L Wright; Lauren Tormey; James Talcott; Mark A Rubin; Massimo Loda; William R Sellers; Jerome P Richie; Philip W Kantoff; Jane C Weeks
Development of an integrated prostate cancer research information system.
Clinical genitourinary cancer 2006;5(1):61-6.
2006: Rameen Beroukhim; Ming Lin; Yuhyun Park; Ke Hao; Xiaojun Zhao; Levi A Garraway; Edward A Fox; Ephraim P Hochberg; Ingo K Mellinghoff; Matthias D Hofer; Aurélien Descazeaud; Mark A Rubin; Matthew Meyerson; Wing Hung Wong; William R Sellers; Cheng Li
Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.
PLoS computational biology 2006;2(5):e41.
2006: Matthias D Hofer; Rainer Kuefer; Wei Huang; Haojie Li; Tarek A Bismar; Sven Perner; Richard E Hautmann; Martin G Sanda; Juergen E Gschwend; Mark A Rubin
Prognostic factors in lymph node-positive prostate cancer.
Urology 2006;67(5):1016-21.
2006: Rainer Kuefer; Kathleen C Day; Celina G Kleer; Michael Sabel; Matthias D Hofer; Sooryanarayana Lnu; Christoph S Zorn; Arul M Chinnaiyan; Mark A Rubin; Mark Day
ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease.
Neoplasia (New York, N.Y.) 2006;8(4):319-29.
2006: Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Lisa R Smith; Diane Roulston; Beth E Helgeson; Xuhong Cao; John T Wei; Mark A Rubin; Rajal B Shah; Arul M Chinnaiyan
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
Cancer research 2006;66(7):3396-400.
2006: Ove Andrén; Katja Fall; Lennart Franzén; Swen-Olof Andersson; Jan-Erik Johansson; Mark A Rubin
How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden.
The Journal of urology 2006;175(4):1337-40.
2006: Kirsten D Mertz; Joëlle Tchinda; R Küfer; P Möller; Mark A Rubin; Holger Moch; Sven Perner
[Cytogenetic alterations in renal tumors. Applications for comparative genomic hybridization and fluorescence in situ hybridization].
Der Urologe. Ausg. A 2006;45(3):316-8, 320-2.
2006: Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Rajal B Shah; Mark A Rubin; Eric Bruening; Vladimir Makarov; Arul M Chinnaiyan
Whole transcriptome amplification for gene expression profiling and development of molecular archives.
Neoplasia (New York, N.Y.) 2006;8(2):153-62.
2006: Scott A Tomlins; Mark A Rubin; Arul M Chinnaiyan
Integrative biology of prostate cancer progression.
Annual review of pathology 2006;1():243-71.
2006: Tarek A Bismar; Francesca Demichelis; Alberto Riva; Robert Kim; Sooryanarayana Lnu; Le He; Jeff Kutok; Jonathan C Aster; Jeffery Tang; Rainer Kuefer; Matthias D Hofer; Phillip G Febbo; Arul M Chinnaiyan; Mark A Rubin
Defining aggressive prostate cancer using a 12-gene model.
Neoplasia (New York, N.Y.) 2006;8(1):59-68.
2005: Aurélien Descazeaud; Mark A Rubin; Yves Allory; Martin Burchardt; Laurent Salomon; Dominique Chopin; Claude C Abbou; Alexandre de la Taille
What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
European urology 2005;48(6):911-5.
2005: Shahriar Koochekpour; Yu-Jun Zhuang; Rameen Beroukhim; Chia-Ling Hsieh; Matthias D Hofer; Haiyen E Zhau; Masao Hiraiwa; Daniel Y Pattan; Joy L Ware; Ronald B Luftig; Konrad Sandhoff; Charles L Sawyers; Kenneth J Pienta; Mark A Rubin; Robert L Vessella; William R Sellers; Oliver Sartor
Amplification and overexpression of prosaposin in prostate cancer.
Genes, chromosomes & cancer 2005;44(4):351-64.
2005: Sooryanarayana Lnu; Jianjun Yu; Bharathi Laxman; Daniel R Rhodes; Rohit Mehra; Scott A Tomlins; Rajal B Shah; Uma Chandran; Federico Monzon; Michael Becich; John T Wei; Kenneth J Pienta; Debashis Ghosh; Mark A Rubin; Arul M Chinnaiyan
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
Cancer cell 2005;8(5):393-406.
2005: Mark A Rubin; Yves Allory; Vincent Molinié; Xavier Leroy; Hugo Faucon; Francis Vacherot; Wei Huang; Adam Kuten; Laurent Salomon; Xavier Rebillard; Olivier Cussenot; Claude C Abbou; Alexandre de la Taille
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome.
Urology 2005;66(5):930-4.
2005: Scott A Tomlins; Daniel R Rhodes; Sven Perner; Saravana M Dhanasekaran; Rohit Mehra; Xiao-Wei Sun; Sooryanarayana Lnu; Xuhong Cao; Joëlle Tchinda; Rainer Kuefer; Charles Lee; James E Montie; Rajal B Shah; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Science (New York, N.Y.) 2005;310(5748):644-8.
2005: Kwanchanit Tantivejkul; Robert D Loberg; Samkeliso C Mawocha; LaShon L Day; Lauren St John; Brian A Pienta; Mark A Rubin; Kenneth J Pienta
PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism.
Journal of cellular biochemistry 2005;96(3):641-52.
2005: Xiaoju Wang; Jianjun Yu; Arun Sreekumar; Sooryanarayana Lnu; Ronglai Shen; Donald Giacherio; Rohit Mehra; James E Montie; Kenneth J Pienta; Martin G Sanda; Philip W Kantoff; Mark A Rubin; John T Wei; Debashis Ghosh; Arul M Chinnaiyan
Autoantibody signatures in prostate cancer.
The New England journal of medicine 2005;353(12):1224-35.
2005: Sunita R Setlur; Mark A Rubin
Current thoughts on the role of the androgen receptor and prostate cancer progression.
Advances in anatomic pathology 2005;12(5):265-70.
2005: Matthias D Hofer; Tara-Jane Browne; Le He; Rolf Skotheim; Ragnhild A Lothe; Mark A Rubin
Identification of two molecular groups of seminomas by using expression and tissue microarrays.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5722-9.
2005: Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew Meyerson; David E Fisher; William R Sellers
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Nature 2005;436(7047):117-22.
2005: Pamela L Paris; Vivian Weinberg; Jeff Simko; Armann Andaya; G Albo; Mark A Rubin; Peter R Carroll; Colin Collins
Preliminary evaluation of prostate cancer metastatic risk biomarkers.
The International journal of biological markers 2005;20(3):141-5.
2005: Charles J Dimitroff; Leyla Descheny; Natalia Trujillo; Robert Kim; Vuong Nguyen; Wei Huang; Kenneth J Pienta; Jeffery L Kutok; Mark A Rubin
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells.
Cancer research 2005;65(13):5750-60.
2005: Xiaojun Zhao; Barbara A Weir; Thomas LaFramboise; Ming Lin; Rameen Beroukhim; Levi A Garraway; Javad Beheshti; Jeffrey C Lee; Katsuhiko Naoki; William G Richards; David J Sugarbaker; Fei Chen; Mark A Rubin; Pasi A Janne; Luc Girard; John D Minna; David C Christiani; Cheng Li; William R Sellers; Matthew Meyerson
Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.
Cancer research 2005;65(13):5561-70.
2005: Tara-Jane Browne; Jerome P Richie; Timothy D Gilligan; Mark A Rubin
Intertubular growth in pure seminomas: associations with poor prognostic parameters.
Human pathology 2005;36(6):640-5.
2005: Mark A Rubin; Tarek A Bismar; Ove Andrén; Lorelei Mucci; Robert Kim; Ronglai Shen; Debashis Ghosh; John T Wei; Arul M Chinnaiyan; Hans-Olov Adami; Philip W Kantoff; Jan-Erik Johansson
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1424-32.
2005: Agnieszka Witkiewicz; Sooryanarayana Lnu; Ronglai Shen; Rohit Mehra; Michael Sabel; Debashis Ghosh; Arul M Chinnaiyan; Mark A Rubin; Celina G Kleer
Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1418-23.
2005: Darlene D Lin; Delray Schultz; Andrew A Renshaw; Mark A Rubin; Jerome P Richie; Anthony V D'Amico
Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era.
Urology 2005;65(3):528-32.
2005: Saravana M Dhanasekaran; Atreya Dash; Jianjun Yu; Ira P Maine; Bharathi Laxman; Scott A Tomlins; Chad J Creighton; Anjana Menon; Mark A Rubin; Arul M Chinnaiyan
Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(2):243-5.
2005: Levi A Garraway; Barbara A Weir; Xiaojun Zhao; Hans R Widlund; Rameen Beroukhim; A Berger; D Rimm; Mark A Rubin; David E Fisher; Matthew Meyerson; William R Sellers
"Lineage addiction" in human cancer: lessons from integrated genomics.
Cold Spring Harbor symposia on quantitative biology 2005;70():25-34.
2005: Robert Kim; Francesca Demichelis; Jeffery Tang; Alberto Riva; Ronglai Shen; Doug F Gibbs; Vasudeva Mahavishno; Arul M Chinnaiyan; Mark A Rubin
Internet-based Profiler system as integrative framework to support translational research.
BMC bioinformatics 2005;6():304.
2004: Rajal B Shah; Rohit Mehra; Arul M Chinnaiyan; Ronglai Shen; Debashis Ghosh; Ming Zhou; Gary R MacVicar; Sooryanarayana Lnu; Jason Harwood; Tarek A Bismar; Robert Kim; Mark A Rubin; Kenneth J Pienta
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.
Cancer research 2004;64(24):9209-16.
2004: Tara-Jane Browne; Michelle S Hirsch; Gilbert Brodsky; William R Welch; Massimo Loda; Mark A Rubin
Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Human pathology 2004;35(12):1462-8.
2004: Mark A Rubin
Using molecular markers to predict outcome.
The Journal of urology 2004;172(5 Pt 2):S18-21; discussion S21-2.
2004: Peter R Carroll; June M Chan; Anthony V D'amico; Edward P Gelmann; Peter Iversen; Laurence Klotz; Joel B Nelson; Peter S Nelson; William G Nelson; William K Oh; Neal Rosen; Mark A Rubin; Howard Sandler; William R Sellers; Matthew R Smith; Jianfeng Xu; Mary Carole McMann; Philip W Kantoff
Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment.
The Journal of urology 2004;172(5 Pt 2):S3-5.
2004: Rajal B Shah; Lakshmi P Kunju; Ronglai Shen; Michele LeBlanc; Ming Zhou; Mark A Rubin
Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
American journal of clinical pathology 2004;122(4):517-23.
2004: Sandro Santagata; Francesca Demichelis; Alberto Riva; Sooryanarayana Lnu; Matthias D Hofer; Jeffery L Kutok; Robert Kim; Jeffery Tang; James E Montie; Arul M Chinnaiyan; Mark A Rubin; Jon C Aster
JAGGED1 expression is associated with prostate cancer metastasis and recurrence.
Cancer research 2004;64(19):6854-7.
2004: Matthias D Hofer; Alice Fecko; Ronglai Shen; Sunita R Setlur; Kenneth J Pienta; Scott A Tomlins; Arul M Chinnaiyan; Mark A Rubin
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
Neoplasia (New York, N.Y.) 2004;6(5):503-12.
2004: Mark A Rubin; Tarek A Bismar; Sarah Curtis; James E Montie
Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?
The American journal of surgical pathology 2004;28(7):946-52.
2004: Pamela L Paris; Armann Andaya; Jane Fridlyand; Ajay N Jain; Vivian Weinberg; David Kowbel; John H Brebner; Jeff Simko; J E Vivienne Watson; Stanislav Volik; Donna G Albertson; Daniel Pinkel; Janneke C Alers; Theo Van der Kwast; Kees J Vissers; Fritz H Schroder; Mark F Wildhagen; Phillip G Febbo; Arul M Chinnaiyan; Kenneth J Pienta; Peter R Carroll; Mark A Rubin; Colin Collins; Herman van Dekken
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.
Human molecular genetics 2004;13(13):1303-13.
2004: Arun Sreekumar; Bharathi Laxman; Daniel R Rhodes; Srilakshmi Bhagavathula; Jason Harwood; Donald Giacherio; Debashis Ghosh; Martin G Sanda; Mark A Rubin; Arul M Chinnaiyan
Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.
Journal of the National Cancer Institute 2004;96(11):834-43.
2004: Mark A Rubin; Sooryanarayana Lnu; Rameen Beroukhim; Scott A Tomlins; Daniel R Rhodes; Pamela L Paris; Matthias D Hofer; Martina Storz-Schweizer; Rainer Kuefer; Jonathan A Fletcher; Bae-Li Hsi; Jennifier A Byrne; Kenneth J Pienta; Colin Collins; William R Sellers; Arul M Chinnaiyan
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
Cancer research 2004;64(11):3814-22.
2004: Cecelia E Schmalbach; Douglas B Chepeha; Thomas J Giordano; Mark A Rubin; Theodoros N Teknos; Carol R Bradford; Gregory T Wolf; Rork Kuick; David E Misek; Douglas K Trask; Samir Hanash
Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma.
Archives of otolaryngology--head & neck surgery 2004;130(3):295-302.
2004: Mark A Rubin; Maciej P Zerkowski; Robert L Camp; Rainer Kuefer; Matthias D Hofer; Arul M Chinnaiyan; David L Rimm
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
The American journal of pathology 2004;164(3):831-40.
2004: Chandan Kumar; Rajal B Shah; Bharathi Laxman; Scott A Tomlins; Jason Harwood; Werner Schmitz; Ernst Conzelmann; Martin G Sanda; John T Wei; Mark A Rubin; Arul M Chinnaiyan
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.
The American journal of pathology 2004;164(3):787-93.
2004: Mark A Rubin; Angelo M DeMarzo
Molecular genetics of human prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(3):380-8.
2004: Mark A Rubin; Philip W Kantoff
Effect of finasteride on risk of prostate cancer: how little we really know.
Journal of cellular biochemistry 2004;91(3):478-82.
2004: Matthias D Hofer; Rainer Kuefer; Sooryanarayana Lnu; Haojie Li; Jing Ma; Geoffrey I Shapiro; Juergen E Gschwend; Richard E Hautmann; Martin G Sanda; Klaudia Giehl; Andre Menke; Arul M Chinnaiyan; Mark A Rubin
The role of metastasis-associated protein 1 in prostate cancer progression.
Cancer research 2004;64(3):825-9.
2004: Willie Underwood; John T Wei; Mark A Rubin; James E Montie; Jennifer Resh; Martin G Sanda
Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
Urologic oncology 2004;22(1):20-4.
2003: Rainer Kuefer; Matthias D Hofer; Juergen E Gschwend; Kenneth J Pienta; Martin G Sanda; Arul M Chinnaiyan; Mark A Rubin; Mark Day
The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(17):6447-52.
2003: Lakshmi P Kunju; Mark A Rubin; Arul M Chinnaiyan; Rajal B Shah
Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations.
American journal of clinical pathology 2003;120(5):737-45.
2003: Celina G Kleer; Qi Cao; Sooryanarayana Lnu; Ronglai Shen; Ichiro Ota; Scott A Tomlins; Debashis Ghosh; Richard G A B Sewalt; Arie P Otte; Daniel F Hayes; Michael Sabel; Donna L Livant; Stephen J Weiss; Mark A Rubin; Arul M Chinnaiyan
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(20):11606-11.
2003: Hassan Chaib; James W MacDonald; Robert L Vessella; Joseph G Washburn; Janna E Quinn; Austin M Odman; Mark A Rubin; Jill A Macoska
Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors.
Genes, chromosomes & cancer 2003;37(3):306-13.
2003: Zheng Fu; Peter C Smith; Lizhi Zhang; Mark A Rubin; Rodney L Dunn; Zhi Yao; Evan T Keller
Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.
Journal of the National Cancer Institute 2003;95(12):878-89.
2003: Yan-Xi Sun; Jingcheng Wang; Charles E Shelburne; Dennis E Lopatin; Arul M Chinnaiyan; Mark A Rubin; Kenneth J Pienta; Russell Taichman
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
Journal of cellular biochemistry 2003;89(3):462-73.
2003: Daniel R Rhodes; Martin G Sanda; Arie P Otte; Arul M Chinnaiyan; Mark A Rubin
Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.
Journal of the National Cancer Institute 2003;95(9):661-8.
2003: Caleb P Nelson; Rodney L Dunn; John T Wei; Mark A Rubin; James E Montie; Martin G Sanda
Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: a tool to facilitate treatment decisions.
Urologic oncology 2003;21(3):213-8.
2003: Ming Zhou; Rajal B Shah; Ronglai Shen; Mark A Rubin
Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
The American journal of surgical pathology 2003;27(3):365-71.
2003: Jonathan Rios-Doria; Kathleen C Day; Rainer Kuefer; Michael G Rashid; Arul M Chinnaiyan; Mark A Rubin; Mark Day
The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells.
The Journal of biological chemistry 2003;278(2):1372-9.
2003: Paul J Kowalski; Mark A Rubin; Celina G Kleer
E-cadherin expression in primary carcinomas of the breast and its distant metastases.
Breast cancer research : BCR 2003;5(6):R217-22.
2003: Wei Xin; Daniel R Rhodes; Collette Ingold; Arul M Chinnaiyan; Mark A Rubin
Dysregulation of the annexin family protein family is associated with prostate cancer progression.
The American journal of pathology 2003;162(1):255-61.
2002: Kristen M Snyder; Mark A Rubin; Barry L Shulkin; Raymond J Hutchinson; Daniel Steven Wechsler
Mediastinal seminoma in a patient with Wiskott-Aldrich syndrome.
Journal of pediatric hematology/oncology 2002;24(8):672-6.
2002: Christopher H Chay; Carlton R Cooper; James D Gendernalik; Saravana M Dhanasekaran; Arul M Chinnaiyan; Mark A Rubin; Alvin H Schmaier; Kenneth J Pienta
A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines.
Urology 2002;60(5):760-5.
2002: Atreya Dash; Ira P Maine; Sooryanarayana Lnu; Ronglai Shen; Arul M Chinnaiyan; Mark A Rubin
Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens.
The American journal of pathology 2002;161(5):1743-8.
2002: Sooryanarayana Lnu; Saravana M Dhanasekaran; Ming Zhou; Terrence barrette; Chandan Kumar; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
The polycomb group protein EZH2 is involved in progression of prostate cancer.
Nature 2002;419(6907):624-9.
2002: Wei Xin; Mark A Rubin; Paul E McKeever
Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst.
Archives of pathology & laboratory medicine 2002;126(10):1174-8.
2002: Rajal B Shah; Ming Zhou; Michele LeBlanc; Matthew Snyder; Mark A Rubin
Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
The American journal of surgical pathology 2002;26(9):1161-8.
2002: Rainer Kuefer; Sooryanarayana Lnu; Ming Zhou; Peter C Lucas; Martin Loeffler; Hubertus Wolter; Torsten Mattfeldt; Richard E Hautmann; Juergen E Gschwend; Terrence barrette; Rodney L Dunn; Arul M Chinnaiyan; Mark A Rubin
alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.
The American journal of pathology 2002;161(3):841-8.
2002: Dinesh Rao; Teresa S Hyun; Priti D Kumar; Ikuko F Mizukami; Mark A Rubin; Peter C Lucas; Martin G Sanda; Theodora S Ross
Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
The Journal of clinical investigation 2002;110(3):351-60.
2002: Daniel R Rhodes; Terrence barrette; Mark A Rubin; Debashis Ghosh; Arul M Chinnaiyan
Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.
Cancer research 2002;62(15):4427-33.
2002: Atreya Dash; Martin G Sanda; Menggang Yu; Jeremy Taylor; Alice Fecko; Mark A Rubin
Prostate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification. American Joint Committee on Cancer.
Urology 2002;60(2):276-80.
2002: Ming Zhou; Arul M Chinnaiyan; Celina G Kleer; Peter C Lucas; Mark A Rubin
Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.
The American journal of surgical pathology 2002;26(7):926-31.
2002: Mark A Rubin
Tech.Sight. Understanding disease cell by cell.
Science (New York, N.Y.) 2002;296(5571):1329-30.
2002: Caleb P Nelson; Mark A Rubin; Myla S Strawderman; James E Montie; Martin G Sanda
Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy.
Urology 2002;59(5):740-5; discussion 745-6.
2002: Güliz Akdas Barkan; Mark A Rubin; Claire W Michael
Diagnosis of melanoma aspirates on ThinPrep: the University of Michigan experience.
Diagnostic cytopathology 2002;26(5):334-9.
2002: Mark A Rubin; Ming Zhou; Saravana M Dhanasekaran; Sooryanarayana Lnu; Terrence barrette; Martin G Sanda; Kenneth J Pienta; Debashis Ghosh; Arul M Chinnaiyan
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
JAMA : the journal of the American Medical Association 2002;287(13):1662-70.
2002: Brian D Seifman; Mark A Rubin; Antoinette L Williams; J. Stuart Wolf, Jr.
Use of absorbable cyanoacrylate glue to repair an open cystotomy.
The Journal of urology 2002;167(4):1872-5.
2002: Mark A Rubin; Rodney Dunn; Myla S Strawderman; Kenneth J Pienta
Tissue microarray sampling strategy for prostate cancer biomarker analysis.
The American journal of surgical pathology 2002;26(3):312-9.
2002: Celina G Kleer; Kenneth L van Golen; Yanhong Zhang; Zhi-Fen Wu; Mark A Rubin; Sofia D Merajver
Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.
The American journal of pathology 2002;160(2):579-84.
2002: Arul M Chinnaiyan; Mark A Rubin
Gene-expression profiles in hereditary breast cancer.
Advances in anatomic pathology 2002;9(1):1-6.
2001: Y Q Wu; H Chen; Mark A Rubin; Kirk J Wojno; Kathleen Cooney
Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
Cancer research 2001;61(24):8651-3.
2001: Ming Zhou; S Hayasaka; Jeremy Taylor; Rajal B Shah; T Proverbs-Singh; S Manley; Mark A Rubin
Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
The Journal of urology 2001;166(6):2193-7.
2001: Mark A Rubin; Bernhard Kleter; Ming Zhou; G Ayala; Antonio L Cubilla; Wim Quint; Edyta C Pirog
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis.
The American journal of pathology 2001;159(4):1211-8.
2001: Mark A Rubin
Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer.
The Journal of pathology 2001;195(1):80-6.
2001: S Manley; NR Mucci; Angelo M DeMarzo; Mark A Rubin
Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.
The American journal of pathology 2001;159(3):837-43.
2001: Saravana M Dhanasekaran; Terrence barrette; Debashis Ghosh; Rajal B Shah; Sooryanarayana Lnu; Kotoku Kurachi; Kenneth J Pienta; Mark A Rubin; Arul M Chinnaiyan
Delineation of prognostic biomarkers in prostate cancer.
Nature 2001;412(6849):822-6.
2001: SJ Kielb; NL Shah; Mark A Rubin; Martin G Sanda
Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer.
The Journal of urology 2001;166(2):482-7.
2001: Mark A Rubin; NR Mucci; J Figurski; A Fecko; Kenneth J Pienta; Mark Day
E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Human pathology 2001;32(7):690-7.
2001: Aaron P Moskalik; Mark A Rubin; Kirk J Wojno; Robert L Bree; Jonathan M Rubin; J Brian Fowlkes; James E Montie; S Manley; Paul Langford Carson
Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2001;20(7):713-22.
2001: Aaron P Moskalik; Paul Langford Carson; Jonathan M Rubin; Robert L Bree; J Brian Fowlkes; Mark A Rubin; Kirk J Wojno; S Manley; James E Montie
Analysis of three-dimensional ultrasound Doppler for the detection of prostate cancer.
Urology 2001;57(6):1128-32.
2001: Rajal B Shah; NR Mucci; A Amin; Jill A Macoska; Mark A Rubin
Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
The American journal of pathology 2001;158(5):1767-73.
2001: Brian D Seifman; Mark A Rubin; Antoinette L Williams; J. Stuart Wolf, Jr.
Functional effects of unilateral laser papillectomy in the pig.
Urology 2001;57(4):832-6.
2001: Robert Marcovich; Antoinette L Williams; Mark A Rubin; J. Stuart Wolf, Jr.
Comparison of 2-octyl cyanoacrylate adhesive, fibrin glue, and suturing for wound closure in the porcine urinary tract.
Urology 2001;57(4):806-10.
2001: Hassan Chaib; Mark A Rubin; NR Mucci; Linheng Li; Mark Day; Johng S Rhim; Jill A Macoska
Activated in prostate cancer: a PDZ domain-containing protein highly expressed in human primary prostate tumors.
Cancer research 2001;61(6):2390-4.
2001: Jill A Macoska; J Xu; D Ziemnicka; Tracy S Schwab; Mark A Rubin; L Kotula
Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma.
Neoplasia (New York, N.Y.) 2001;3(2):99-104.
2001: Slade L Spencer; Mark A Rubin; Hero Hussain; J. Stuart Wolf, Jr.
Complete transurethral resection of bladder endocervicosis.
The Journal of urology 2001;165(2):524.
2001: Michael G Rashid; Martin G Sanda; CJ Vallorosi; Jonathan Rios-Doria; Mark A Rubin; Mark Day
Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.
Cancer research 2001;61(2):489-92.
2001: Hassan Chaib; E K Cockrell; Mark A Rubin; Jill A Macoska
Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis.
Neoplasia (New York, N.Y.) 2001;3(1):43-52.
2001: Ming Zhou; A Patel; Mark A Rubin
Prevalence and location of peripheral nerve found on prostate needle biopsy.
American journal of clinical pathology 2001;115(1):39-43.
2001: Mark A Rubin; NR Mucci; S Manley; Martin G Sanda; E Cushenberry; Myla S Strawderman; James E Montie; Nadir Bassily
Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
The Journal of urology 2001;165(1):114-8.
2000: NR Mucci; Mark A Rubin; Myla S Strawderman; James E Montie; David C Smith; Kenneth J Pienta
Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens.
Journal of the National Cancer Institute 2000;92(23):1941-2.
2000: Mark A Rubin; Rodney Dunn; N Kambham; C P Misick; K M O'Toole
Should a Gleason score be assigned to a minute focus of carcinoma on prostate biopsy?
The American journal of surgical pathology 2000;24(12):1634-40.
2000: Rajal B Shah; Nadir Bassily; John T Wei; NR Mucci; James E Montie; Martin G Sanda; Mark A Rubin
Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.
Urology 2000;56(5):721-5.
2000: Brent K Hollenbeck; Nadir Bassily; John T Wei; James E Montie; S Hayasaka; Jeremy Taylor; Mark A Rubin
Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features.
The Journal of urology 2000;164(5):1583-6.
2000: Erin E Perrone; Constantine Theoharis; NR Mucci; S Hayasaka; Jeremy Taylor; Kathleen Cooney; Mark A Rubin
Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men.
Journal of the National Cancer Institute 2000;92(11):937-9.
2000: Robert Marcovich; Kirk J Wojno; John T Wei; Mark A Rubin; James E Montie; Martin G Sanda
Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer.
Urology 2000;55(6):904-8.
2000: NR Mucci; G Akdas; S Manely; Mark A Rubin
Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
Human pathology 2000;31(4):406-14.
2000: Mark A Rubin; MJ Putzi; NR Mucci; David C Smith; Kirk J Wojno; Susan Korenchuk; Kenneth J Pienta
Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):1038-45.
2000: Nadir Bassily; CJ Vallorosi; G Akdas; James E Montie; Mark A Rubin
Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
American journal of clinical pathology 2000;113(3):383-8.
2000: CJ Vallorosi; Kathleen C Day; Xin Zhao; Michael G Rashid; Mark A Rubin; K R Johnson; M J Wheelock; Mark Day
Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution.
The Journal of biological chemistry 2000;275(5):3328-34.
2000: Mark A Rubin; Nadir Bassily; Martin G Sanda; James E Montie; Myla S Strawderman; Kirk J Wojno
Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.
The American journal of surgical pathology 2000;24(2):183-9.